| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |
From the Department of Otolaryngology,*
School of
Medicine, and the Department of Molecular Virology and
Oncology,
Cancer Research Institute, Kanazawa
University, Kanazawa, Japan; and the Department of
Otolaryngology,
School of Medicine, National
Taiwan University, Taipei, Taiwan
Nasopharyngeal carcinoma (NPC) is distinctive in head and neck carcinomas for its close association with Epstein-Barr virus and its highly metastatic nature. Up-regulation of cell motility is essential for enhancement of metastatic potential. The expression of c-Met proto-oncogene, a high-affinity receptor for hepatocyte growth factor/scatter factor, has been reported to correlate with metastatic ability of the tumor cell. We observed close association of c-Met expression with cervical lymph node metastasis (P = 0.0272) in 39 NPC specimens studied immunohistochemically. Epstein-Barr virus-encoding latent membrane protein-1 (LMP-1) is a primary oncogene and is suggested to enhance the metastatic property of NPC. Previously, we reported that LMP-1 enhanced the motility of Madin-Darby canine kidney (MDCK) epithelial cells that was mediated by activation of Ets-1 transcription factor. Therefore, we examined the interrelationships of LMP-1, Ets-1, and c-Met. In immunohistochemical studies, the expression of LMP-1, Ets-1, and c-Met correlated significantly with each other in NPC (LMP-1 versus Ets-1, P < 0.0001; Ets-1 versus c-Met, P = 0.0012; LMP-1 versus Met, P = 0.0005). Transfection of LMP-1-expressing plasmid in MDCK cells induced c-Met protein expression. The c-Met protein was also induced by Ets-1 expression, and induction of c-Met by LMP-1 was suppressed by introducing a dominant-negative form of Ets-1 in LMP-1-expressing MDCK cells. These results suggest that LMP-1 induces c-Met through the activation of Ets-1, which may contribute in part to the highly metastatic potential of NPC.
This article has been cited by other articles:
 |
|
 |
|
  J.-H. Lin, C.-H. Tsai, J.-S. Chu, J.-Y. Chen, K. Takada, and J.-Y. Shew Dysregulation of HER2/HER3 Signaling Axis in Epstein-Barr Virus-Infected Breast Carcinoma Cells J. Virol., June 1, 2007; 81(11): 5705 - 5713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dutton, C. B. Woodman, M. B. Chukwuma, J. I. K. Last, W. Wei, M. Vockerodt, K. R. N. Baumforth, J. R. Flavell, M. Rowe, A. M. R. Taylor, et al. Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells Blood, March 15, 2007; 109(6): 2597 - 2603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Horikawa, J. Yang, S. Kondo, T. Yoshizaki, I. Joab, M. Furukawa, and J. S. Pagano Twist and Epithelial-Mesenchymal Transition Are Induced by the EBV Oncoprotein Latent Membrane Protein 1 and Are Associated with Metastatic Nasopharyngeal Carcinoma Cancer Res., March 1, 2007; 67(5): 1970 - 1978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kondo, T. Yoshizaki, N. Wakisaka, T. Horikawa, S. Murono, K. L. Jang, I. Joab, M. Furukawa, and J. S. Pagano MUC1 Induced by Epstein-Barr Virus Latent Membrane Protein 1 Causes Dissociation of the Cell-Matrix Interaction and Cellular Invasiveness via STAT Signaling J. Virol., February 15, 2007; 81(4): 1554 - 1562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-S. Lin, G. J. Berry, W. E. Fee Jr, D. J. Terris, and Z. Sun Identification of Tyrosine Kinases Overexpressed in Head and Neck Cancer Arch Otolaryngol Head Neck Surg, March 1, 2004; 130(3): 311 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Ma, T. Kijima, G. Maulik, E. A. Fox, M. Sattler, J. D. Griffin, B. E. Johnson, and R. Salgia c-MET Mutational Analysis in Small Cell Lung Cancer: Novel Juxtamembrane Domain Mutations Regulating Cytoskeletal Functions Cancer Res., October 1, 2003; 63(19): 6272 - 6281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Dawson, G. Tramountanis, A. G. Eliopoulos, and L. S. Young Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) Activates the Phosphatidylinositol 3-Kinase/Akt Pathway to Promote Cell Survival and Induce Actin Filament Remodeling J. Biol. Chem., January 31, 2003; 278(6): 3694 - 3704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lu, H.-H. Chua, S.-Y. Chen, J.-Y. Chen, and C.-H. Tsai Regulation of Matrix Metalloproteinase-1 by Epstein-Barr Virus Proteins Cancer Res., January 1, 2003; 63(1): 256 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Walker, S. Kermorgant, E. Darai, P. Madelenat, A. C. Cremieux, D. Henin, and T. Lehy Hepatocyte Growth Factor and c-Met in Cervical Intraepithelial Neoplasia: Overexpression of Proteins Associated with Oncogenic Human Papillomavirus and Human Immunodeficiency Virus Clin. Cancer Res., January 1, 2003; 9(1): 273 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-N. Tsai, C.-L. Tsai, K.-P. Tse, H.-Y. Chang, and Y.-S. Chang The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases PNAS, July 23, 2002; 99(15): 10084 - 10089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-N. Qian, X. Guo, B. Cao, E. J. Kort, C.-C. Lee, J. Chen, L.-M. Wang, W.-Y. Mai, H.-Q. Min, M.-H. Hong, et al. Met Protein Expression Level Correlates with Survival in Patients with Late-stage Nasopharyngeal Carcinoma Cancer Res., January 1, 2002; 62(2): 589 - 596. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
